⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14169733 | 1.00 | — | — | |
| SCHEMBL4224385 | 0.96 | — | — | |
| SCHEMBL13135724 | 0.92 | — | — | |
| SCHEMBL16878002 | 0.88 | MET (0.35) | — | |
| SCHEMBL20455733 | 0.88 | MET (0.35) | — | |
| SCHEMBL20455506 | 0.88 | MET (0.35) | — | |
| SCHEMBL18759857 | 0.88 | MET (0.35) | — | |
| SCHEMBL9675320 | 0.87 | — | — | |
| SCHEMBL55925 | 0.87 | — | — | |
| Water SCHEMBL21545065 | 0.85 | MET (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4313980-B1 | LACTIVICIN COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS | FEDORA PHARMACEUTICALS INC (CA) | 2026-04-22 | — | — | EP | claimed |
| EP-4720035-A1 | LIPID COMPOUNDS, COMPOSITIONS, AND USES THEREOF | LIBERATE BIO, INC. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4696694-A1 | ANTIBIOTIC RIFABUTIN ANALOGS | BioVersys AG (CH) | 2026-02-18 | — | — | EP | claimed |
| US-20250387402-A1 | POLYSUBSTITUTED BENZENE COMPOUND AND PREPARATION METHOD AND USE THEREOF | EVOPOINT BIOSCIENCES CO LTD (CN) | 2025-12-25 | — | — | US | claimed |
| WO-2024249525-A1 | LIPID COMPOUNDS, COMPOSITIONS, AND USES THEREOF | LIBERATE BIO, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| EP-4247800-B1 | N-SUBSTITUTED 4-(1,3-ARYLOXAZOLO-2-YL)PHENYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HOFFMANN LA ROCHE (CH) | 2024-11-13 | — | — | EP | claimed |
| WO-2021212039-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | Pardes Biosciences, Inc. (US) | 2021-10-21 | — | — | WO | claimed |
| US-20210308141-A1 | POLYSUBSTITUTED BENZENE COMPOUND AND PREPARATION METHOD AND USE THEREOF | Evopoint Biosciences Co., Ltd. (CN) | 2021-10-07 | — | — | US | claimed |
| EP-3831822-A1 | POLYSUBSTITUTED BENZENE COMPOUND AND PREPARATION METHOD AND USE THEREOF | Suzhou Sinovent Pharmaceuticals Co., Ltd. (CN) | 2021-06-09 | — | — | EP | claimed |
| EP-2694472-B1 | SULFONAMIDE DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICALS CO (JP) | 2020-03-11 | — | — | EP | claimed |
| US-9527807-B2 | Sulfonamide derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-12-27 | — | — | US | claimed |
| US-20140024650-A1 | SULFONAMIDE DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-01-23 | — | — | US | claimed |
| EP-0996619-A1 | TROPANE ANALOGS AND METHODS FOR INHIBITION OF MONOAMINE TRANSPORT | ORGANIX, INC. (US) | 2000-05-03 | — | — | EP | claimed |
| WO-1999002526-A1 | TROPANE ANALOGS AND METHODS FOR INHIBITION OF MONOAMINE TRANSPORT | ORGANIX, INC. (US) | 1999-01-21 | — | — | WO | claimed |
| EP-4727939-A1 | 5-(CINNOLIN-6-YL)THIAZOLE COMPOUNDS FOR TREATING NEUROLOGICAL DISORDERS | Prothena Biosciences Limited (IE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4720035-A1 | LIPID COMPOUNDS, COMPOSITIONS, AND USES THEREOF | LIBERATE BIO, INC. (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4695238-A1 | CDK2 INHIBITORS | Blueprint Medicines Corporation (US) | 2026-02-18 | — | — | EP | disclosed |
| US-4567283-A | EPOXYCYCLOHEXANOLS | SHELL OIL COMPANY (US) | 1986-01-28 | — | — | US | disclosed |
| US-4554366-A | HERBICIDES, PLANT GROWTH REGULATORS | SHELL OIL COMPANY (US) | 1985-11-19 | — | — | US | disclosed |
| US-4542244-A | Oxabicycloalkane herbicides | SHELL OIL COMPANY (US) | 1985-09-17 | — | — | US | disclosed |